14. September 2023 | Legal
U.S. Naloxone Report Highlights The Competitive Scenario With Impact Of Drivers And Challenges 2030 | Novartis AG, Indivior Plc., ADAPT Pharma, Inc., Amphastar Pharmaceuticals, Inc., INSYS Therapeutics, Inc.
U.S. Naloxone Report Highlights The Competitive Scenario With Impact Of Drivers And Challenges 2030 | Novartis AG, Indivior Plc., ADAPT Pharma, Inc., Amphastar Pharmaceuticals, Inc., INSYS Therapeutics, Inc.
The U.S. naloxone market is estim...